Telemetry Investments LLC has recently announced that it has increased stake in Fresh Tracks Therapeutics Inc. (NASDAQ:FRTX) by 173.73%. After grabbing 66000.0 shares, the institutional investor is now in possession of 41889.0 shares of the Healthcare Company. The new investment brought the stake of investor firm to 2.19% having worth around $0.13 million. Moreover, Thrivent Trust Co. increased its share by 39876.0 to have a control over 41243.0 shares. And Millennium Management LLC raised its holdings to 17603.0 shares by acquiring 28730.0 shares or 0.95% of the stake.
Fresh Tracks Therapeutics Inc. (FRTX) concluded trading on 01/11/23 at a closing price of $1.84, with 1.36 million shares of worth about $2.49 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -45.88% during that period and on Wednesday the price saw a gain of about 7.60%. Currently the company’s common shares owned by public are about 3.01M shares, out of which, 2.98M shares are available for trading.
A deeper look into what the analysts at Wall Street are thinking about the price target of this stock provides us with the following: 1 analysts are covering the FRTX stock and their offered price forecasts bring an average price target of $12.00. Over the next 12 months, analysts forecasted that the stock’s price could jump as high as $12.00 and could fall to a lowest price of $12.00. The stock’s current price level is 59.11% above of average price target set by the analysts, while a rise to estimated low would result in gain of 84.67% for the stock. However, touching the estimated high of $12.00 would mean a gain of 84.67% for the stock.
According to filings with the U.S. Securities and Exchange Commission (SEC), insiders took part in trade of the company’s stock for 0 times over the past 12 months. They bought 0 shares in 0 of the transactions. In 0 selling transactions, insiders dumped 0 shares.
Vanguard Extended Market Index Fu, Fidelity Extended Market Index Fu, and SQUAD Point Five are the top 3 mutual funds which are holding stakes in Fresh Tracks Therapeutics Inc. Vanguard Extended Market Index Fu is currently holding 27779.0 shares of worth totaling $52780.0. The company recently came buying 0.0 shares which brought its stake up to 0.92% of the company’s outstanding shares. SQUAD Point Five, after buying 3120.0 shares, have now control over 0.10% of the stake in the company. It holds 2514.0 shares of worth $5928.0.
Fresh Tracks Therapeutics Inc. (NASDAQ: FRTX) started trading at $1.70, below -$0.01 from concluding price of the previous day. However, the stock later moved at a day high price of 2.0000, or with a gain of 7.60%. Stock saw a price change of 13.58% in past 5 days and over the past one month there was a price change of 17.20%. Year-to-date (YTD), FRTX shares are showing a performance of 22.67% which decreased to -81.51% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $1.30 but also hit the highest price of $18.94 during that period. The average intraday trading volume for Fresh Tracks Therapeutics Inc. shares is 41.58K. The stock is currently trading 22.28% above its 20-day simple moving average (SMA20), while that difference is up 7.36% for SMA50 and it goes to -60.36% lower than SMA200.
Telemetry Investments LLC acquired 66000.0 shares of Fresh Tracks Therapeutics Inc. having value of about $0.13 million. Data submitted at the U.S SEC by Telemetry Investments LLC revealed that the firm now holds 41889.0 shares in the company valued at close to $77075.76, or have control over 173.73% stake in the company. Fresh Tracks Therapeutics Inc. (NASDAQ: FRTX) currently have 3.01M outstanding shares and institutions hold larger chunk of about 11.90% of that. Holding of mutual funds in the company is about 1.50% while other institutional holders and individual stake holders have control over 5.98% and — of the stake respectively.
The stock has a current market capitalization of $5.45M and its 3Y-monthly beta is at 0.30. It has posted earnings per share of -$8.57 in the same period. It has Quick Ratio of 4.40 while making debt-to-equity ratio of 0.00. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for FRTX, volatility over the week remained 9.65% while standing at 10.51% over the month.
Analysts are in expectations that Fresh Tracks Therapeutics Inc. (FRTX) stock would likely to be making an EPS of -$1.89 in the current quarter, while forecast for next quarter EPS is -$0.91 and it is -$5.23 for next year. For the current quarter EPS, analysts have given the company a lowest target -$1.96 which is -$1.82 at the higher side of the target for the same. When we compare those targets with actual EPS, we find that company posted an EPS of -$7.2 in the same quarter a year ago. Stock’s fiscal year EPS is expected to rise by 42.40% while it is estimated to increase by 26.70% in next year.
Analysts at 1 brokerage firms have issued recommendations for the Fresh Tracks Therapeutics Inc. (FRTX)’s stock and average of those rates the stock at a “Moderate Buy” and assign it a score of 2.00. Out of those 1 Wall Street analysts, 1 recommended a “Buy” rating, while 0 were in favor recommending the stock as a “Hold” and 0 analyst recommended the stock as “Sell”.